This study investigates how beta cell-derived cholecystokinin drives obesity-associated pancreatic cancer development, showing that targeting endocrine signaling could prevent tumor progression in obesity-related contexts.
This study investigates multidisciplinary management of infected iliocaval stents in uterine cancer, showing surgical resection controls infection and enables oncologic treatment resumption despite high complication risks.
This study investigates burnout in U.S. hematology-oncology physicians specializing in sickle cell disease, showing higher burnout rates linked to systemic factors, reduced recreation, and lower job pride.
This study investigates the safety of adding berzosertib, an ATR inhibitor enhancing cancer cell sensitivity to DNA damage, to standard chemoradiation for advanced head and neck cancers, finding tolerability but no improvement in response rates.
Yale Medicine Magazine was originally established in the 1950s as the medical school's alumni bulletin. Its articles cover discoveries in biomedicine, clinical advances, new ways of training tomorrow’s doctors, and the evolution of medicine and health care.